America’s first CRISPR trial is still nearly 100% effective 3 years on

Incredible new data presented recently at the European Hematology Association Congress has revealed an experimental CRISPR gene editing therapy is both safe and effective up to three years after treatment. The follow-up results come from one of the longest-running human trials using CRISPR technology to treat a pair of rare genetic blood diseases.

Source: America’s first CRISPR trial is still nearly 100% effective 3 years on

Leave a Reply